96337-25-6 Usage
Uses
Used in Biochemical Research:
H-ARG-ARG-ARG-ARG-ARG-ARG-OH TRIFLUOROACETATE SALT is used as a research tool for studying the role of arginine in biological processes and its interactions with other molecules.
Used in Pharmaceutical Development:
H-ARG-ARG-ARG-ARG-ARG-ARG-OH TRIFLUOROACETATE SALT serves as a building block or a component in the development of new pharmaceuticals targeting various health conditions, given its unique structure and properties.
Used in Peptide-based Drug Production:
H-ARG-ARG-ARG-ARG-ARG-ARG-OH TRIFLUOROACETATE SALT is utilized in the synthesis of peptide-based drugs, leveraging its stability and solubility-enhancing properties to improve drug delivery and efficacy.
Used in Immune System Modulation:
Given arginine's importance in immune system function, H-ARG-ARG-ARG-ARG-ARG-ARG-OH TRIFLUOROACETATE SALT may be employed in applications aimed at modulating or enhancing immune responses for therapeutic purposes.
Used in Protein Synthesis Studies:
H-ARG-ARG-ARG-ARG-ARG-ARG-OH TRIFLUOROACETATE SALT can be used to investigate the mechanisms of protein synthesis and the role of arginine in this process, contributing to a better understanding of cellular functions and potential therapeutic targets.
Used in Solubility and Stability Enhancement:
H-ARG-ARG-ARG-ARG-ARG-ARG-OH TRIFLUOROACETATE SALT is used to improve the solubility and stability of other compounds in experimental or therapeutic settings, facilitating their use in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 96337-25-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,3,3 and 7 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 96337-25:
(7*9)+(6*6)+(5*3)+(4*3)+(3*7)+(2*2)+(1*5)=156
156 % 10 = 6
So 96337-25-6 is a valid CAS Registry Number.
96337-25-6Relevant academic research and scientific papers
Novel conjugates of polysaccharides and uses thereof
-
Page/Page column 17, (2008/06/13)
Novel conjugates composed of a saccharide-containing moiety (e.g., aminoglycosides) covalently linked to a moiety containing two or more basic amino acid residues (e.g., a polyarginine) and processes of preparing same are disclosed. Further disclosed are
Treatment of cytomegalovirus infection
-
, (2008/06/13)
Described herein are anti-cytomegalovirus peptides. In a preferred embodiment, the peptide is acetyl-[D-Arg]9 -NH2. The use of these peptides, either per se or in combination with other anti-CMV compounds, is disclosed as an effective method for controlling CMV infection.
